Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Bringing together academics, clinicians and members of the public to explore the possibilities and challenges of vaccines for cancer prevention.

We are in an exciting era for cancer prevention. In Oxford and elsewhere, research scientists are working on the development of vaccines that might prevent the development of cancer in people with a range of conditions that put them at higher risk of cancer.

Concurrently, public awareness and discussion around vaccines have been heightened by the rise in vaccine hesitancy and the reach of vaccine misinformation. 

OxCODE and the Centre for Personalised Medicine, together with the Oxford Cancer Cancer Vaccines PPI Panel, designed an event in June 2025 focussed around vaccines for preventing cancer. Our aim was to bring together academics, clinicians, members of the public, and other key stakeholders to explore the possibilities and challenges of this exciting new era for cancer research.  

The team invited a panel of national leaders and patient representatives to convene for an afternoon of talks and discussion. The programme was designed to combine presentations from expert stakeholders with panel discussions and questions from the delegates, including 20 patients, carers and members of the public who travelled from across England to join the conversation.

There was plenty of stimulating and lively discussion, with questions and contributions from multiple perspectives. For a full breakdown of the day, including public discussion points and next steps, see the Oxford Cancer Vaccines Hub. 

Similar stories

Fallopian tube immune cells could offer new route to prevent and treat ovarian cancer

Research led by Professor Ahmed Ahmed and Dr Nancy Zaarour has identified a population of immune cells in the fallopian tubes that can recognise ovarian cancer cells, raising the possibility of harnessing the body's early immune defences to develop new ways to prevent or treat the disease.

Professor Bethan Psaila wins ISEH Janet Rowley Award

Congratulations to Professor Psaila, who has received the 2026 Janet Rowley Award from the International Society for Experimental Hematology, in recognition of her outstanding contributions in the field of experimental haematology.

Similar stories

Fallopian tube immune cells could offer new route to prevent and treat ovarian cancer

Research led by Professor Ahmed Ahmed and Dr Nancy Zaarour has identified a population of immune cells in the fallopian tubes that can recognise ovarian cancer cells, raising the possibility of harnessing the body's early immune defences to develop new ways to prevent or treat the disease.

Professor Bethan Psaila wins ISEH Janet Rowley Award

Congratulations to Professor Psaila, who has received the 2026 Janet Rowley Award from the International Society for Experimental Hematology, in recognition of her outstanding contributions in the field of experimental haematology.